BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38527429)

  • 1. The Intersection of Epigenetic Alterations and Developmental State in Pediatric Ependymomas.
    Kardian AS; Mack S
    Dev Neurosci; 2024 Mar; ():. PubMed ID: 38527429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental origins and oncogenic pathways in malignant brain tumors.
    Lu QR; Qian L; Zhou X
    Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic therapies in haematological malignancies: searching for true targets.
    Altucci L; Minucci S
    Eur J Cancer; 2009 May; 45(7):1137-1145. PubMed ID: 19346125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in pediatric solid tumors: promising new targets.
    Lawlor ER; Thiele CJ
    Clin Cancer Res; 2012 May; 18(10):2768-79. PubMed ID: 22589485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas.
    Lewis R; Li YD; Hoffman L; Hashizume R; Gravohac G; Rice G; Wadhwani NR; Jie C; Pundy T; Mania-Farnell B; Mayanil CS; Soares MB; Lei T; James CD; Foreman NK; Tomita T; Xi G
    Neoplasia; 2019 Jun; 21(6):505-515. PubMed ID: 31005631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms regulating neural development and pediatric brain tumor formation.
    Faria CM; Rutka JT; Smith C; Kongkham P
    J Neurosurg Pediatr; 2011 Aug; 8(2):119-32. PubMed ID: 21806352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
    Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
    Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
    Skouras P; Markouli M; Strepkos D; Piperi C
    Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel.
    Huchedé P; Leblond P; Castets M
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
    Postwala H; Shah Y; Parekh PS; Chorawala MR
    Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma epigenetics: From subclassification to novel treatment options.
    Gusyatiner O; Hegi ME
    Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between epigenetic regulation, dietary habits, and the developmental origins of health and disease theory.
    Mochizuki K; Hariya N; Honma K; Goda T
    Congenit Anom (Kyoto); 2017 Nov; 57(6):184-190. PubMed ID: 28169463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic therapy of hematological malignancies: where are we now?
    Popovic R; Shah MY; Licht JD
    Ther Adv Hematol; 2013 Apr; 4(2):81-91. PubMed ID: 23610616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
    Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growing role of epigenetics in childhood cancers.
    Panditharatna E; Filbin MG
    Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of histone modifications in epigenetic transitions during normal and perturbed development.
    Kubicek S; Schotta G; Lachner M; Sengupta R; Kohlmaier A; Perez-Burgos L; Linderson Y; Martens JH; O'Sullivan RJ; Fodor BD; Yonezawa M; Peters AH; Jenuwein T
    Ernst Schering Res Found Workshop; 2006; (57):1-27. PubMed ID: 16568946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
    Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
    J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
    Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.